Andrew Boyer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

AMRX

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$613,846	—	$1,912,500	—	$471,658	$19,159	$3,017,163
2024	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$600,000	—	$1,620,975	—	$554,400	$18,927	$2,794,302
2023	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$600,000	—	$741,438	—	$582,720	$18,531	$1,942,689
2022	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$600,000	—	$1,626,572	—	$438,480	$16,886	$2,681,937
2021	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$600,000	—	$1,534,657	—	$484,800	$16,406	$2,635,863
2020	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$660,084	—	$1,239,735	—	$492,480	$16,213	$2,386,531
2019	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$660,084	—	$1,391,119	$1,046,868	—	$15,008	$3,113,079
2018	Amneal Pharmaceuticals, Inc. (AMRX)	EVP, Chief Commercial Officer - Generics	$412,500	—	$999,996	$2,000,003	$448,083	$924	$3,861,506

No earnings-call appearances or filed executive changes recorded yet.